La Jolla, CA – A cellular receptor that balances the accumulation of fat and fat burning in the body may be a new target for anti-obesity and cholesterol-fighting drugs, according to a Salk Institute study.
La Jolla, CA – A molecule that naturally degrades a protein linked to Alzheimer’s disease appears to reduce the levels of that protein by nearly 50 percent when delivered by gene therapy, researchers at the Salk Institute and UC San Diego have found in collaboration with researchers at the University of Kentucky. The findings appear in the March 15 issue of the Journal of Neuroscience.
La Jolla, CA – Research at the Salk Institute has identified a gene that may link certain pesticides and chemical weaponry to a number of neurological disorders, including the elusive Gulf War syndrome and attention deficit/hyperactivity disorder (ADHD).
La Jolla, CA – The Salk Institute for Biological Studies has been ranked as one of the nation’s leaders in molecular biology and genetics research by a publication that monitors trends and performances in basic research.
La Jolla, CA – A California research team has mapped an entire group of human enzymes, providing important information for the development of a new generation of drugs to treat cancer and other diseases. The findings will be published in the Dec. 6 issue of Science.
La Jolla, CA – Sydney Brenner, a distinguished professor at the Salk Institute for Biological Studies, is one of three recipients of this year’s Nobel Prize in medicine for his contributions toward discoveries about how genes regulate organ growth and the process of programmed cell death.
La Jolla, CA – HIV selectively inserts itself into active areas of a host cell’s genome, Salk Institute researchers have found for the first time. The fact that the virus hooks itself up to areas of the cell’s genome that are busy expressing themselves may help explain why HIV can replicate, or reproduce itself, so rapidly. The findings are being published as the cover article in the Friday, August 23, issue of the journal Cell.
La Jolla, CA – A crucial piece of the puzzle into how the eye becomes wired to the brain has been revealed by scientists at the Salk Institute for Biological Studies in La Jolla, Calif., and UT Southwestern Medical Center at Dallas.
La Jolla, CA – A team led by Salk Institute scientists may have discovered how viruses can “hit and run” a cell’s genetic machinery to trigger cancer and exit without a trace.
La Jolla, CA – In recognition of its deep commitment to Morse High School students, the Salk Institute has been awarded the ‘Exemplary Partnerships Award’ and the ‘Ten-Year Partnerships Award’ by San Diego City Schools.
La Jolla, CA – A team led by Salk Institute scientists has used gene therapy to reverse infertility in male mice. Treated mice produced healthy offspring that did not contain the introduced gene or vector, alleviating concerns that treating infertility via gene therapy would genetically alter any progeny produced from the treatment, as well as their descendants in perpetuity.
La Jolla, CA – A team led by Salk scientists has identified the probable link between the breast cancer drug Herceptin and cardiac failure, one of its common side effects. The results may also explain why a common combination drug regimen including Herceptin is particularly toxic.
La Jolla, CA – Salk Institute scientists have observed for the first time that new cells in the adult brain grow and mature over time, functioning just like any of their neighboring neurons.
La Jolla, CA – According to accepted dogma, the brain responds to sensory experiences somewhat like an electronic bucket brigade, with incoming signals passed from one region to the next in a somewhat linear fashion.
La Jolla, CA – In the first global survey of its kind, scientists at The Salk Institute have isolated a genetic switch that controls how plants growing at different latitudes respond to light. The variation ensures that plants in northern climes near the poles, for example, are more sensitive to light than their counterparts closer to the equator.
La Jolla, CA – Salk scientists have identified a new potential drug target for type II diabetes that may offer a specific treatment to complement existing therapies. The new target, a protein called CREB (for cyclic AMP response binding), acts in a pathway independent of that targeted by the thiazolidinediones, currently considered the most effective drugs for managing the condition.
La Jolla, CA – Salk scientists have created an animal model for autoimmune diseases that closely mirrors the perplexing patterns of symptoms observed in human autoimmunity, including an increased susceptibility of females over males.
La Jolla, CA – Though a rose, carnation or tulip each has its own distinguishing feel, look and smell, they all share one common trait: the flower’s petals adorn its perimeter while the reproductive organs sit in the flower’s center.